Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mind Medicine Mindmed Inc
(NQ:
MNMD
)
6.140
-0.160 (-2.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine Mindmed Inc
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
31
32
Next >
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
June 23, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 23, 2022
On Thursday, 216 stocks hit new 52-week lows.
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 22, 2022
June 22, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50
Via
Benzinga
Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
June 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 17, 2022
June 17, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 16, 2022
June 16, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 15, 2022
June 15, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62
Via
Benzinga
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
June 15, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From June 14, 2022
June 14, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
June 13, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 10, 2022
June 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67
Via
Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
June 09, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
June 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
June 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
June 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36
Via
Benzinga
Jefferies Global Healthcare Conference: Three Psychedelic Biotech Companies To Participate This Week
June 06, 2022
The 2022 Jefferies Global Healthcare Conference is an annual gathering where over 500 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity...
Via
Benzinga
Awakn Life Sciences Files Patent For Exclusive Rights To Use Ketamine For Treating Behavioral Addictions
June 06, 2022
Photo by Adrien Converse on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 3, 2022
June 03, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
June 02, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75
Via
Benzinga
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
June 02, 2022
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its...
Via
Benzinga
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
June 01, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 31, 2022
May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36
Via
Benzinga
Psychedelic Compounds-Based Stocks Continue To Decline
May 29, 2022
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From May 26, 2022
May 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34
Via
Benzinga
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today
May 25, 2022
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45
Via
Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
May 24, 2022
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 24, 2022
May 24, 2022
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61
Via
Benzinga
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
May 24, 2022
Mind Medicine Names New CEO Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) has hired Schond L. Greenway to oversee its finance department.
Via
Benzinga
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
May 23, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68
Via
Benzinga
MindMed Appoints Schond L. Greenway As CFO
May 23, 2022
Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO.
Via
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.